FundedIQ
Biotechnology

Metabolon: Funding, Investors & Team (Oct 2026)

Metabolon is a technology company that specializes in developing analytical methods and software for biomarker discovery through metabolomics. Their expertise in data and translational science allows them to help customers and partners address complex questions in the life sciences, speeding up research and improving outcomes. They offer customizable multiomics solutions, including metabolomics and lipidomics, to support customers from discovery to clinical trials and beyond. Metabolon aims to provide biochemical data and insights that enhance the impact of life sciences research and seamlessly integrate with other 'omics' technologies.

www.metabolon.com LinkedIn Morrisville, United States 251-500 employees
Biotechnology Health Care Health Diagnostics Life Science Software
Total raised
$60.0M
Rounds
1
Latest
Undisclosed round
May 2024

Metabolon has raised $60.0M across 1 funding round on record, the most recent an undisclosed round of $60.0M announced in May 2024.

That round is above the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.

Metabolon Company Profile and Key Stats

Total funding raised
$60.0M
across 1 round on record
Funding rounds on record
1
Latest funding round
Undisclosed round
$60.0M in May 2024
Employees
251-500
reported band
Headquarters
Morrisville, United States

Latest funding round on record: May 2024.

Metabolon Funding Rounds

Date
Round
Amount
Undisclosed round
$60.0M

Metabolon Founders and Leadership Team

Name
Role
Contact
Lisa Millet
Founder
—

No contact details are on record for this team yet.

Metabolon Funding Compared to Other Biotechnology Startups

Segment
Companies
Median round
4,185
$8.1M
30,234
$7.6M

Metabolon's latest round of $60.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.

Funded Startups Like Metabolon in Biotechnology and Morrisville

Companies Similar to Metabolon

Series B $150M

Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…

Undisclosed round $94.0M

Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…

Series B $9.5M

Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…

Series B $33.0M

Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…

Undisclosed round —

Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.

Series A $15.0M

Serán is a contract development and manufacturing organization providing a comprehensive suite of…

Private Equity —

Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…

Series D $250M

Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…

Series E $311M

Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…

Undisclosed round $8.5M

Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational…

Series E $92.5M

Evvy is for people with vaginas who want to be empowered with information about their microbiome. Their…

Series B $40.0M

Metabolon Funding FAQs

What does Metabolon do?

Metabolon is a technology company that specializes in developing analytical methods and software for biomarker discovery through metabolomics. Their expertise in data and translational science allows them to help customers and partners address complex questions in the life sciences, speeding up research and improving outcomes. They offer customizable multiomics solutions, including metabolomics and lipidomics, to support customers from discovery to clinical trials and beyond. Metabolon aims to provide biochemical data and insights that enhance the impact of life sciences research and seamlessly integrate with other 'omics' technologies.

How much funding has Metabolon raised?

Metabolon has raised $60.0M across 1 round on record. The most recent is an undisclosed round of $60.0M announced in May 2024.

When did Metabolon last raise funding?

Metabolon's most recent funding round on record is an undisclosed round of $60.0M, announced in May 2024.

Who founded Metabolon?

FundedIQ lists Lisa Millet (Founder) at Metabolon.

Where is Metabolon headquartered?

Metabolon is based in Morrisville, North Carolina, United States.

How many employees does Metabolon have?

Metabolon is in the 251-500 employee band.

How does Metabolon's funding compare to other Biotechnology startups?

Metabolon's latest round of $60.0M is above the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.

About FundedIQ's Metabolon Funding Data

FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.

Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Metabolon is left off this page rather than filled in.

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.

Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.